These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 7723224)

  • 1. Effects of a thromboxane A2-receptor antagonist, a thromboxane synthetase inhibitor and aspirin on prostaglandin I2 production in endothelium-intact and -injured aorta of guinea pigs.
    Higo K; Karasawa A
    Jpn J Pharmacol; 1994 Dec; 66(4):471-9. PubMed ID: 7723224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological studies on the TXA2 synthetase inhibitor (E)-3-[p-(1H-imidazol-1-ylmethyl)phenyl]-2-propenoic acid (OKY-046).
    Hiraku S; Taniguchi K; Wakitani K; Omawari N; Kira H; Miyamoto T; Okegawa T; Kawasaki A; Ujiie A
    Jpn J Pharmacol; 1986 Jul; 41(3):393-401. PubMed ID: 3093741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of KW-3635, a novel dibenzoxepin derivative of a selective thromboxane A2 antagonist, on human, guinea pig and rat platelets.
    Miki I; Kishibayashi N; Nonaka H; Ohshima E; Takami H; Obase H; Ishii A
    Jpn J Pharmacol; 1992 Jul; 59(3):357-64. PubMed ID: 1434130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiplatelet effects of the novel thromboxane A2 receptor antagonist sodium (E)-11-[2-(5,6-dimethyl-1-benzimidazolyl)-ethylidene]-6,11- dihydrodibenz[b,e] oxepine-2-carboxylate monohydrate.
    Karasawa A; Kawakage M; Shirakura S; Higo K; Kubo K; Ohshima E; Obase H
    Arzneimittelforschung; 1991 Dec; 41(12):1230-6. PubMed ID: 1840011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative study of prostaglandin I2 (PG I2) and thromboxane A2 (TXA2) synthetase inhibitor (OKY-1581) on hemodynamics in pregnant dogs.
    Murayama K; Kasai H; Adachi T; Utsunomiya O; Ouchi H
    Nihon Sanka Fujinka Gakkai Zasshi; 1983 Mar; 35(3):344-50. PubMed ID: 6339650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of OKY-046, a thromboxane A2 synthetase inhibitor, on arachidonate-induced platelet aggregation: possible role of "prostaglandin H2 steal" mechanism.
    Kuzuya T; Hoshida S; Yamagishi M; Ohmori M; Inoue M; Kamada T; Tada M
    Jpn Circ J; 1986 Nov; 50(11):1071-8. PubMed ID: 3102802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Actions of the novel thromboxane A2 receptor antagonist sodium (E)-11-[2-(5,6-dimethyl-1-benzimidazolyl)-ethylidene]-6,11- dihydrodibenz[b,e]oxepine-1-carboxylate monohydrate on smooth muscle preparations.
    Karasawa A; Shirakura S; Higo K; Kubo K
    Arzneimittelforschung; 1991 Dec; 41(12):1237-41. PubMed ID: 1815522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antithrombotic effects of KW-3635, a thromboxane A2-receptor antagonist, in guinea pigs.
    Shirakura S; Higo K; Takeda M; Karasawa A
    Jpn J Pharmacol; 1994 Jun; 65(2):93-8. PubMed ID: 7967232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The combined use of prostaglandin I2 analogue (OP-2507) and thromboxane A2 synthetase inhibitor (OKY-046) strongly inhibits atherosclerosis of aortic allografts in rats.
    Hirano T; Nakafusa Y; Kawano R; Motoyama K; Arima T; Sugitani A; Tanaka M
    Surgery; 2001 May; 129(5):595-605. PubMed ID: 11331452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the effects of anti-thromboxane agents in platelet-vessel wall interaction.
    Buccellati C; Ciceri P; Ballerio R; Casagrande C; Folco G; Nicosia S
    Eur J Pharmacol; 2002 May; 443(1-3):133-41. PubMed ID: 12044803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory effect of KW-3635, a new thromboxane A2-receptor antagonist, on arterial thrombosis in guinea pigs.
    Higo K; Karasawa A
    Jpn J Pharmacol; 1993 Dec; 63(4):521-3. PubMed ID: 8121085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vasorelaxing effects of prostaglandin I2 on the canine basilar and coronary arteries.
    Shirahase H; Usui H; Manabe K; Kurahashi K; Fujiwara M
    J Pharmacol Exp Ther; 1989 Feb; 248(2):769-73. PubMed ID: 2645398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stimulation of vessel wall prostacyclin by selective thromboxane synthetase inhibitor OKY 1581.
    Mehta J; Mehta P; Ostrowski N
    Prostaglandins Leukot Med; 1983 Sep; 12(1):49-52. PubMed ID: 6356153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased production of eicosanoids, TXA2, PGI2 and LTC4 in experimental spinal cord injuries.
    Mitsuhashi T; Ikata T; Morimoto K; Tonai T; Katoh S
    Paraplegia; 1994 Aug; 32(8):524-30. PubMed ID: 7970857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological characterization of FCE 27262, a combined thromboxane synthase inhibitor and PGH2/TXA2 receptor antagonist.
    Vaghi F; Colombo M; Pierucci L; Volpi D; Dho L; Ukmar G; Rosa B; Salvati P
    Drugs Exp Clin Res; 1993; 19(6):249-60. PubMed ID: 8013268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of the infusion of OKY-046, a thromboxane A2 synthase inhibitor, on urinary metabolites of prostacyclin and thromboxane A2 in healthy human subjects.
    Morio H; Hirai A; Terano T; Tamura Y; Yoshida S
    Thromb Haemost; 1993 Mar; 69(3):276-81. PubMed ID: 8470052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of high glucose concentration and a thromboxane synthase inhibitor on the production of thromboxane A2 and prostaglandin I2 and E2 by retinal endothelial cells.
    Sone H; Okuda Y; Kawakami Y; Yamashita K
    Life Sci; 1996; 58(3):239-43. PubMed ID: 9499164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen potentiates constrictor prostanoid function in female rat aorta by upregulation of cyclooxygenase-2 and thromboxane pathway expression.
    Li M; Kuo L; Stallone JN
    Am J Physiol Heart Circ Physiol; 2008 Jun; 294(6):H2444-55. PubMed ID: 18310519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of a thromboxane A2 synthesis inhibitor and a prostaglandin I2 analogue on experimental acute necrotizing pancreatitis in rats.
    Iida T; Yokoi H; Kawarada Y
    Pancreas; 1998 Aug; 17(2):140-7. PubMed ID: 9700944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological characterization of cinnamophilin, a novel dual inhibitor of thromboxane synthase and thromboxane A2 receptor.
    Yu SM; Wu TS; Teng CM
    Br J Pharmacol; 1994 Mar; 111(3):906-12. PubMed ID: 8019768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.